Activity of CHS 828 in primary cultures of human hematological and solid tumors in vitro - PubMed

Comparative Study

Activity of CHS 828 in primary cultures of human hematological and solid tumors in vitro

A Aleskog et al. Anticancer Drugs. 2001 Nov.

Abstract

CHS 828 is a pyridyl cyanoguanidine that has shown promising preclinical anticancer activity against various experimental tumor models and is presently being tested in a phase II trial in man. In the present study the fluorometric microculture cytotoxicity assay was used for in vitro evaluation of CHS 828 activity in primary cell cultures from hematological and solid tumors. In total, 156 samples from various diagnoses were tested with 72-h continuous drug exposure. CHS 828 showed high relative in vitro activity against tumor cells from chronic lymphocytic leukemia as well as from acute leukemia and high-grade lymphoma. Activity was also observed in several solid tumor cell samples, although the group as a whole appeared less responsive. CHS 828 was significantly more active against hematological malignancies compared to normal lymphocytes. Correlation analysis with standard drugs revealed low to moderate correlation coefficients. The results show that CHS 828 has potent antitumor activity against primary cultures of human tumor cells from patients and might have a unique mechanism of action.

Similar articles

• In vitro activity of the novel cytotoxic agent CHS 828 in childhood acute leukemia.

  Frost BM, Lönnerholm G, Nygren P, Larsson R, Lindhagen E. Frost BM, et al. Anticancer Drugs. 2002 Aug;13(7):735-42. doi: 10.1097/00001813-200208000-00008. Anticancer Drugs. 2002. PMID: 12187330

• Cytotoxic effect in vivo and in vitro of CHS 828 on human myeloma cell lines.

  Hovstadius P, Lindhagen E, Hassan S, Nilsson K, Jernberg-Wiklund H, Nygren P, Binderup L, Larsson R. Hovstadius P, et al. Anticancer Drugs. 2004 Jan;15(1):63-70. doi: 10.1097/00001813-200401000-00010. Anticancer Drugs. 2004. PMID: 15090745

• A hollow fiber model for in vitro studies of cytotoxic compounds: activity of the cyanoguanidine CHS 828.

  Hassan SB, de la Torre M, Nygren P, Karlsson MO, Larsson R, Jonsson E. Hassan SB, et al. Anticancer Drugs. 2001 Jan;12(1):33-42. doi: 10.1097/00001813-200101000-00005. Anticancer Drugs. 2001. PMID: 11272284

• Guanidino-containing drugs in cancer chemotherapy: biochemical and clinical pharmacology.

  Ekelund S, Nygren P, Larsson R. Ekelund S, et al. Biochem Pharmacol. 2001 May 15;61(10):1183-93. doi: 10.1016/s0006-2952(01)00570-6. Biochem Pharmacol. 2001. PMID: 11322922 Review.

• Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia.

  Fuggetta MP, D'Onofrio C, Bonmassar E. Fuggetta MP, et al. Ann Ist Super Sanita. 1990;26(3-4):385-95. Ann Ist Super Sanita. 1990. PMID: 1708953 Review.

Cited by

• Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer.

  Li SL, Huang CH, Lin CC, Huang ZN, Chern JH, Lien HY, Wu YY, Cheng CH, Chang CY, Chuu JJ. Li SL, et al. Invest New Drugs. 2011 Apr;29(2):195-206. doi: 10.1007/s10637-009-9337-2. Epub 2009 Dec 5. Invest New Drugs. 2011. PMID: 19960226

• Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartments.

  Fuchs D, Christofferson R, Stridsberg M, Lindhagen E, Azarbayjani F. Fuchs D, et al. J Transl Med. 2009 Mar 12;7:16. doi: 10.1186/1479-5876-7-16. J Transl Med. 2009. PMID: 19284605 Free PMC article.

• The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors.

  Watson M, Roulston A, Bélec L, Billot X, Marcellus R, Bédard D, Bernier C, Branchaud S, Chan H, Dairi K, Gilbert K, Goulet D, Gratton MO, Isakau H, Jang A, Khadir A, Koch E, Lavoie M, Lawless M, Nguyen M, Paquette D, Turcotte E, Berger A, Mitchell M, Shore GC, Beauparlant P. Watson M, et al. Mol Cell Biol. 2009 Nov;29(21):5872-88. doi: 10.1128/MCB.00112-09. Epub 2009 Aug 24. Mol Cell Biol. 2009. PMID: 19703994 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer